Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $33 Million - $43 Million
160,000 New
160,000 $33.1 Million
Q4 2021

Feb 15, 2022

SELL
$351.38 - $448.68 $37.2 Million - $47.5 Million
-105,970 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $39.5 Million - $48.6 Million
105,970 New
105,970 $45.1 Million
Q4 2019

Feb 14, 2020

SELL
$126.05 - $152.76 $15.7 Million - $19 Million
-124,600 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $5.13 Million - $6.18 Million
41,600 Added 50.12%
124,600 $17.5 Million
Q1 2019

May 15, 2019

BUY
$104.82 - $146.73 $8.7 Million - $12.2 Million
83,000 New
83,000 $12 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.64B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track 1832 Asset Management L.P. Portfolio

Follow 1832 Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.